Clinical trials
Recruiting Gallbladder Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Bayer | 1 |
| Beijing Biotech | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Jazz Pharmaceuticals | 1 |
| Lu Wang, MD, PhD | 1 |
| RenJi Hospital | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Neoplasms | 14 |
| Cholangiocarcinoma | 9 |
| Biliary Tract Neoplasms | 7 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Bile Duct Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
| Klatskin Tumor | 2 |
| Appendiceal Neoplasms | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.